SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Analysts at Sidoti Csr reduced their Q3 2025 earnings estimates for SBC Medical Group in a research note issued to investors on Tuesday, May 20th. Sidoti Csr analyst A. Shah now expects that the company will earn $0.13 per share for the quarter, down from their prior estimate of $0.14. The consensus estimate for SBC Medical Group's current full-year earnings is $5.02 per share. Sidoti Csr also issued estimates for SBC Medical Group's Q4 2025 earnings at $0.13 EPS, Q1 2026 earnings at $0.14 EPS, Q2 2026 earnings at $0.14 EPS, Q3 2026 earnings at $0.14 EPS, Q4 2026 earnings at $0.16 EPS and FY2026 earnings at $0.58 EPS.
SBC Medical Group (NASDAQ:SBC - Get Free Report) last posted its quarterly earnings results on Thursday, May 15th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.10. The firm had revenue of $47.33 million for the quarter, compared to analysts' expectations of $51.52 million.
SBC Medical Group Price Performance
SBC Medical Group stock traded up $0.71 during trading hours on Wednesday, hitting $4.55. The stock had a trading volume of 185,526 shares, compared to its average volume of 57,689. The company has a quick ratio of 2.76, a current ratio of 2.79 and a debt-to-equity ratio of 0.06. The stock's fifty day moving average is $3.54 and its two-hundred day moving average is $4.76. SBC Medical Group has a 1-year low of $2.62 and a 1-year high of $12.50.
About SBC Medical Group
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Read More
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
